发明名称 METHOD FOR ESTIMATING CLINICAL COURSE SEVERITY OF STREPTOCOCCAL IMPETIGO CASES
摘要 FIELD: medicine. ^ SUBSTANCE: method involves examining testee blood serum samples on tablets covered with sorbable F(ab)2-fragments of idiotypic and anti-idiotypic antibodies to tumor necrosis factor TNFalpha (TNFalpha itself is applicable instead of F(ab)2-fragments of anti-idiotypic antibodies to TNFalpha). Concentration of idiotypic and anti-idiotypic antibodies to TNFalpha is determined in testing. The value under study not violating the limit of 145% relative to reference blood serum response, streptococcal impetigo clinical course is estimated as mild one. One or both determined values being higher than 145% but not exceeding 175%, streptococcal impetigo clinical course is estimated as moderate one. One or both determined values exceeding 175%, streptococcal impetigo clinical course is estimated as heavy one. ^ EFFECT: high accuracy and objectivity of estimates.
申请公布号 RU2262702(C1) 申请公布日期 2005.10.20
申请号 RU20040110215 申请日期 2004.04.06
申请人 发明人 VOLKOVA E.N.;BUTOV JU.S.;GNEDENKO B.B.;MOROZOV S.G.
分类号 G01N33/53 主分类号 G01N33/53
代理机构 代理人
主权项
地址